dougan sk - Search Results

Year	Number of Results
2005	1
2007	3
2008	2
2009	3
2010	1
2011	2
2012	3
2013	4
2014	5
2015	4
2016	5
2017	11
2018	10
2019	5
2020	3
2021	0

1

Dougan SK. Dougan SK. Cancer J. 2017 Nov/Dec;23(6):321-325. doi: 10.1097/PPO.0000000000000288. Cancer J. 2017. PMID: 29189327 Review.

2

GM-CSF, IL-3, and IL-5 Family of Cytokines: Regulators of Inflammation.

Dougan M, Dranoff G, Dougan SK. Dougan M, et al. Among authors: dougan sk. Immunity. 2019 Apr 16;50(4):796-811. doi: 10.1016/j.immuni.2019.03.022. Immunity. 2019. PMID: 30995500 Free article. Review.

3

Molecular Pathways of Colon Inflammation Induced by Cancer Immunotherapy.

Luoma AM, Suo S, Williams HL, Sharova T, Sullivan K, Manos M, Bowling P, Hodi FS, Rahma O, Sullivan RJ, Boland GM, Nowak JA, Dougan SK, Dougan M, Yuan GC, Wucherpfennig KW. Luoma AM, et al. Among authors: dougan sk. Cell. 2020 Aug 6;182(3):655-671.e22. doi: 10.1016/j.cell.2020.06.001. Epub 2020 Jun 29. Cell. 2020. PMID: 32603654

4

Broadening the Impact of Immunotherapy to Pancreatic Cancer: Challenges and Opportunities.

Balachandran VP, Beatty GL, Dougan SK. Balachandran VP, et al. Among authors: dougan sk. Gastroenterology. 2019 May;156(7):2056-2072. doi: 10.1053/j.gastro.2018.12.038. Epub 2019 Jan 18. Gastroenterology. 2019. PMID: 30660727 Free PMC article. Review.

5

Targeting Immunotherapy to the Tumor Microenvironment.

Dougan M, Dougan SK. Dougan M, et al. Among authors: dougan sk. J Cell Biochem. 2017 Oct;118(10):3049-3054. doi: 10.1002/jcb.26005. Epub 2017 May 15. J Cell Biochem. 2017. PMID: 28332219 Review.

6

CEACAM1 regulates TIM-3-mediated tolerance and exhaustion.

Huang YH, Zhu C, Kondo Y, Anderson AC, Gandhi A, Russell A, Dougan SK, Petersen BS, Melum E, Pertel T, Clayton KL, Raab M, Chen Q, Beauchemin N, Yazaki PJ, Pyzik M, Ostrowski MA, Glickman JN, Rudd CE, Ploegh HL, Franke A, Petsko GA, Kuchroo VK, Blumberg RS. Huang YH, et al. Among authors: dougan sk. Nature. 2015 Jan 15;517(7534):386-90. doi: 10.1038/nature13848. Epub 2014 Oct 26. Nature. 2015. PMID: 25363763 Free PMC article.

7

Increasing the efficiency of precise genome editing with CRISPR-Cas9 by inhibition of nonhomologous end joining.

Maruyama T, Dougan SK, Truttmann MC, Bilate AM, Ingram JR, Ploegh HL. Maruyama T, et al. Among authors: dougan sk. Nat Biotechnol. 2015 May;33(5):538-42. doi: 10.1038/nbt.3190. Epub 2015 Mar 23. Nat Biotechnol. 2015. PMID: 25798939 Free PMC article.

8

In vivo discovery of immunotherapy targets in the tumour microenvironment.

Zhou P, Shaffer DR, Alvarez Arias DA, Nakazaki Y, Pos W, Torres AJ, Cremasco V, Dougan SK, Cowley GS, Elpek K, Brogdon J, Lamb J, Turley SJ, Ploegh HL, Root DE, Love JC, Dranoff G, Hacohen N, Cantor H, Wucherpfennig KW. Zhou P, et al. Among authors: dougan sk. Nature. 2014 Feb 6;506(7486):52-7. doi: 10.1038/nature12988. Epub 2014 Jan 29. Nature. 2014. PMID: 24476824 Free PMC article.

9

Localized CD47 blockade enhances immunotherapy for murine melanoma.

Ingram JR, Blomberg OS, Sockolosky JT, Ali L, Schmidt FI, Pishesha N, Espinosa C, Dougan SK, Garcia KC, Ploegh HL, Dougan M. Ingram JR, et al. Among authors: dougan sk. Proc Natl Acad Sci U S A. 2017 Sep 19;114(38):10184-10189. doi: 10.1073/pnas.1710776114. Epub 2017 Sep 5. Proc Natl Acad Sci U S A. 2017. PMID: 28874561 Free PMC article.

10

Targeting Cytokine Therapy to the Pancreatic Tumor Microenvironment Using PD-L1-Specific VHHs.

Dougan M, Ingram JR, Jeong HJ, Mosaheb MM, Bruck PT, Ali L, Pishesha N, Blomberg O, Tyler PM, Servos MM, Rashidian M, Nguyen QD, von Andrian UH, Ploegh HL, Dougan SK. Dougan M, et al. Among authors: dougan sk. Cancer Immunol Res. 2018 Apr;6(4):389-401. doi: 10.1158/2326-6066.CIR-17-0495. Epub 2018 Feb 19. Cancer Immunol Res. 2018. PMID: 29459478 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results